These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12237474)

  • 1. Cannabinoid receptor-G protein interactions: G(alphai1)-bound structures of IC3 and a mutant with altered G protein specificity.
    Ulfers AL; McMurry JL; Miller A; Wang L; Kendall DA; Mierke DF
    Protein Sci; 2002 Oct; 11(10):2526-31. PubMed ID: 12237474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the third intracellular loop of the human cannabinoid 1 receptor.
    Ulfers AL; McMurry JL; Kendall DA; Mierke DF
    Biochemistry; 2002 Sep; 41(38):11344-50. PubMed ID: 12234176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural domains of the CB1 cannabinoid receptor that contribute to constitutive activity and G-protein sequestration.
    Nie J; Lewis DL
    J Neurosci; 2001 Nov; 21(22):8758-64. PubMed ID: 11698587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proximal and distal C-terminal tail domains of the CB1 cannabinoid receptor mediate G protein coupling.
    Nie J; Lewis DL
    Neuroscience; 2001; 107(1):161-7. PubMed ID: 11744255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dopamine D2 receptor mutant capable of G protein-mediated signaling but deficient in arrestin binding.
    Lan H; Liu Y; Bell MI; Gurevich VV; Neve KA
    Mol Pharmacol; 2009 Jan; 75(1):113-23. PubMed ID: 18809670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, expression, and characterization of a synthetic human cannabinoid receptor and cannabinoid receptor/ G-protein fusion protein.
    Farrens DL; Dunham TD; Fay JF; Dews IC; Caldwell J; Nauert B
    J Pept Res; 2002 Dec; 60(6):336-47. PubMed ID: 12464112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of a highly conserved aspartate residue in the second transmembrane domain of the cannabinoid receptors, CB1 and CB2, disrupts G-protein coupling.
    Tao Q; Abood ME
    J Pharmacol Exp Ther; 1998 May; 285(2):651-8. PubMed ID: 9580609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain.
    Mukhopadhyay S; McIntosh HH; Houston DB; Howlett AC
    Mol Pharmacol; 2000 Jan; 57(1):162-70. PubMed ID: 10617691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CB1 cannabinoid receptor in the brain.
    Howlett AC
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):405-16. PubMed ID: 9974174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of CB1 cannabinoid receptors using receptor peptide fragments and site-directed antibodies.
    Howlett AC; Song C; Berglund BA; Wilken GH; Pigg JJ
    Mol Pharmacol; 1998 Mar; 53(3):504-10. PubMed ID: 9495818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An invertebrate G-protein coupled receptor is a chimeric cannabinoid/melanocortin receptor.
    Elphick MR
    Brain Res; 1998 Jan; 780(1):170-3. PubMed ID: 9497095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example.
    Wager-Miller J; Westenbroek R; Mackie K
    Chem Phys Lipids; 2002 Dec; 121(1-2):83-9. PubMed ID: 12505693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational analysis of the CB1 carboxyl-terminus in the receptor-G protein complex.
    Shim JY; Khurana L; Kendall DA
    Proteins; 2016 Apr; 84(4):532-43. PubMed ID: 26994549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of Pro-258 in transmembrane domain 6 constitutively activates the G protein-coupled alpha-factor receptor.
    Konopka JB; Margarit SM; Dube P
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6764-9. PubMed ID: 8692892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand based structural studies of the CB1 cannabinoid receptor.
    Picone RP; Fournier DJ; Makriyannis A
    J Pept Res; 2002 Dec; 60(6):348-56. PubMed ID: 12464113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A region of the sulfonylurea receptor critical for a modulation of ATP-sensitive K(+) channels by G-protein betagamma-subunits.
    Wada Y; Yamashita T; Imai K; Miura R; Takao K; Nishi M; Takeshima H; Asano T; Morishita R; Nishizawa K; Kokubun S; Nukada T
    EMBO J; 2000 Sep; 19(18):4915-25. PubMed ID: 10990455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.
    Merkouris M; Dragatsis I; Megaritis G; Konidakis G; Zioudrou C; Milligan G; Georgoussi Z
    Mol Pharmacol; 1996 Oct; 50(4):985-93. PubMed ID: 8863845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel class of monocyclic and bicyclic alkyl amides that exhibit CB1 and CB2 cannabinoid receptor affinity and receptor activation.
    Berglund BA; Fleming PR; Rice KC; Shim JY; Welsh WJ; Howlett AC
    Drug Des Discov; 2000; 16(4):281-94. PubMed ID: 10807034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the third intracellular loop of the neutrophil N-formyl peptide receptor in G protein coupling.
    Prossnitz ER; Quehenberger O; Cochrane CG; Ye RD
    Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):581-7. PubMed ID: 8373373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The third cytoplasmic domain of the GLP-1[7-36 amide] receptor is required for coupling to the adenylyl cyclase system.
    Takhar S; Gyomorey S; Su RC; Mathi SK; Li X; Wheeler MB
    Endocrinology; 1996 May; 137(5):2175-8. PubMed ID: 8612565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.